GBIO
Generation Bio Co.Company Information
- Company Name
- Generation Bio Co.
- CIK
- CIK0001733294
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- GBIO: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- GBIO
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-01-13
- Last sale
- 2024-07-01
- Shares purchased (TTM)
- 85,000
- Shares sold (TTM)
- 6,719
Institutional Sentiment
- As of
- 2025-12-31
- Institutional shares owned
- 3,981,713
- Shares outstanding
- 6,735,454
- Ownership
- 59.12%
Earnings Market Reaction
- Filing date
- 2025-11-05
- Price on filing date
- —
- 1-month reaction
- 2.70%
- 3-month reaction
- 9.54%
Balance Sheet
Values in millions ($)| Line item | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 22 | 49 | 51 | 76 | 22 | 28 | 36 | 66 | 93 | 145 | 96 | 93 | ||||||
| Marketable Securities Current | 68 | 92 | 107 | 109 | 163 | 188 | 184 | 198 | 198 | 169 | 193 | 186 | ||||||
| Accounts Receivable Related Parties | - | - | - | - | - | - | - | - | - | - | 48 | - | ||||||
| Receivables Net Current | - | - | - | - | - | - | 0 | 4 | 1 | 0 | 2 | 0 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 1 | 1 | 2 | 1 | - | - | - | - | - | - | ||||||
| Nontrade Receivables Current | - | - | - | - | 0 | 0 | - | 4 | - | - | - | - | ||||||
| Assets Held For Sale Not Part Of Disposal Group Current | 3 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 2 | 4 | 6 | 6 | 4 | 5 | 5 | 4 | 6 | 6 | 7 | 8 | ||||||
| Restricted Cash Current | - | - | 0 | - | - | - | 2 | - | - | - | - | - | ||||||
| Assets Current | 93 | 146 | 165 | 193 | 191 | 223 | 227 | 273 | 298 | 321 | 345 | 287 | ||||||
| Marketable Securities Noncurrent | - | - | - | - | 15 | - | 15 | - | - | - | - | - | ||||||
| Property Plant And Equipment Net | 9 | 13 | 14 | 15 | 16 | 17 | 19 | 26 | 22 | 22 | 22 | 22 | ||||||
| Operating Lease Right Of Use Asset | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 70 | 54 | 56 | 58 | 59 | ||||||
| Deferred Costs | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Restricted Cash Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 6 | 6 | 6 | 6 | 6 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 1 | 3 | 0 | 0 | 1 | 1 | 0 | 1 | 2 | ||||||
| Assets | 122 | 179 | 201 | 231 | 249 | 265 | 286 | 375 | 381 | 405 | 431 | 376 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 2 | 2 | 2 | 1 | 2 | 2 | 1 | 2 | 3 | 2 | 2 | 1 | ||||||
| Accrued Liabilities And Other Liabilities | 12 | 6 | 6 | 10 | 6 | 6 | 6 | 17 | 9 | 8 | 8 | 11 | ||||||
| Contract With Customer Liability Current | - | - | - | - | - | - | - | - | - | - | 6 | - | ||||||
| Deferred Revenue Current | 0 | 2 | 2 | 11 | 12 | 14 | 13 | 13 | 12 | 8 | - | 0 | ||||||
| Operating Lease Liability Current | 6 | 10 | 9 | 13 | 11 | 9 | 8 | 8 | 9 | 8 | 8 | 7 | ||||||
| Liabilities Current | 21 | 19 | 20 | 35 | 30 | 30 | 28 | 40 | 33 | 26 | 23 | 19 | ||||||
| Contract With Customer Liability Noncurrent | - | - | - | - | - | - | - | - | - | - | 55 | - | ||||||
| Deferred Revenue Noncurrent | 31 | 30 | 30 | 29 | 31 | 34 | 38 | 42 | 46 | 52 | - | 0 | ||||||
| Operating Lease Liability Noncurrent | 20 | 76 | 78 | 81 | 83 | 85 | 88 | 90 | 71 | 72 | 74 | 75 | ||||||
| Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 71 | 125 | 128 | 145 | 144 | 150 | 154 | 172 | 150 | 151 | 152 | 94 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 795 | 793 | 791 | 789 | 786 | 782 | 778 | 774 | 768 | 762 | 756 | 727 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | -0 | 0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -744 | -739 | -718 | -703 | -682 | -666 | -646 | -571 | -536 | -508 | -477 | -445 | ||||||
| Stockholders Equity | 51 | 54 | 73 | 86 | 104 | 115 | 132 | 203 | 232 | 254 | 279 | 282 | ||||||
| Liabilities And Stockholders Equity | 122 | 179 | 201 | 231 | 249 | 265 | 286 | 375 | 381 | 405 | 431 | 376 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | ||||||
| Shares Outstanding | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialGeneration Bio Co. (GBIO) — SEC Financial Statements & Analysis
Generation Bio Co. (GBIO) is a pharmaceutical preparations company. Generation Bio Co. trades on Nasdaq as: GBIO. Generation Bio Co. (GBIO)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-05. Based on that filing, On profitability, Generation Bio Co. posts an operating margin of -457.06%, a net margin of -410.13%, a Return on Equity (ROE) of -80.81%, a Return on Assets (ROA) of -33.79%, and a Return on Invested Capital (ROIC) of -129.51%. Per share, it reports EPS of $-9.30, diluted EPS of $-9.30, free cash flow per share of $-17.03, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -17.82% year-over-year, net income growth of -56.95% year-over-year, and EPS growth of -57.34% year-over-year. On the balance sheet, it maintains a current ratio of 4.44x, a quick ratio of 4.33x, working capital of $72.42M, a debt-to-equity ratio of 1.41x, a debt ratio of 0.59, free cash flow of $-114.73M (TTM), and net debt of $-24.09M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-9.30
- ROE TTM
- -80.81%
- ROA TTM
- -33.79%
- Debt To Equity
- 1.41x
- Free Cash Flow TTM
- $-114.73M
- Net Revenue TTM Growth 1Y
- -17.82%
Data as of 2025-09-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Generation Bio Co. in?
Generation Bio Co. (GBIO) operates in the Pharmaceutical Preparations industry.
What exchange does GBIO trade on?
Generation Bio Co. (GBIO) trades on the Nasdaq.
When was Generation Bio Co. (GBIO)'s most recent SEC filing?
Generation Bio Co. (GBIO)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-05.
What is GBIO's EPS (earnings per share)?
Generation Bio Co. (GBIO)'s trailing twelve month EPS is $-9.30 as of 2025-09-30.
What is GBIO's ROE (return on equity)?
Generation Bio Co. (GBIO)'s trailing twelve month Return on Equity (ROE) is -80.81% as of 2025-09-30.
What is GBIO's ROA (return on assets)?
Generation Bio Co. (GBIO)'s trailing twelve month Return on Assets (ROA) is -33.79% as of 2025-09-30.
What is GBIO's ROIC (return on invested capital)?
Generation Bio Co. (GBIO)'s trailing twelve month Return on Invested Capital (ROIC) is -129.51% as of 2025-09-30.